Sort   by:  
 Page size 
UnknownCDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in KIT D816V+ Neoplastic Mast Cells.
Not available
S-EPMC9264943 | biostudies-literature
UnknownEuro area sovereign bond risk premia before and during the Covid-19 pandemic.
Not available
S-EPMC9925421 | biostudies-literature
UnknownTuning biological processes <i>via</i> co-solutes: from single proteins to protein condensates - the case of α-elastin condensation.
Not available
S-EPMC11883817 | biostudies-literature
Unknown“I didn’t mean it that way...”: Design and evaluation of an elective course on dealing with discrimination in medical communication „So war das nicht gemeint ...“: Konzeption und Evaluation eines Wahlfachs zum Umgang mit Diskriminierung in der medizinischen Kommunikation
Not available
S-EPMC12286879 | biostudies-literature
UnknownIdentification of a leukemia-initiating stem cell in human mast cell leukemia.
Not available
S-EPMC6839966 | biostudies-literature
UnknownP1014: OVERALL SURVIVAL IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS RECEIVING AVAPRITINIB VERSUS MIDOSTAURIN OR CLADRIBINE
Not available
S-EPMC9429350 | biostudies-literature
UnknownP1015: DURATION OF TREATMENT AND REDUCTION IN SERUM TRYPTASE LEVELS IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS TREATED WITH AVAPRITINIB VERSUS BEST AVAILABLE THERAPY
Not available
S-EPMC9429120 | biostudies-literature
UnknownRandom encounters dominate water-water interactions at supercritical conditions.
Not available
S-EPMC11908480 | biostudies-literature
UnknownIdentification of bromodomain-containing protein-4 as a novel marker and epigenetic target in mast cell leukemia.
Not available
S-EPMC4610040 | biostudies-literature
UnknownEfficacy of avapritinib versus best available therapy in the treatment of advanced systemic mastocytosis.
Not available
S-EPMC9343245 | biostudies-literature
Sort   by:  
 Page size